BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32003945)

  • 1. Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135).
    Jones S; Yarbrough AL; Fantegrossi WE; Prather PL; Bush JM; Radominska-Pandya A; Fujiwara R
    Pharmacol Res Perspect; 2020 Feb; 8(1):e00561. PubMed ID: 32003945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes.
    Gandhi AS; Wohlfarth A; Zhu M; Pang S; Castaneto M; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2015 Mar; 7(3):187-98. PubMed ID: 24827428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48.
    Holm NB; Nielsen LM; Linnet K
    AAPS J; 2015 Sep; 17(5):1237-45. PubMed ID: 26002511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity.
    Pinson A; Yarbrough AL; Bush JM; Cabanlong CV; Shoeib A; Jackson BK; Fukuda S; Gogoi J; Fantegrossi WE; McCain K; Prather PL; Fujiwara R; Radominska-Pandya A
    Pharmacol Biochem Behav; 2020 Aug; 195():172949. PubMed ID: 32413436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.
    Chimalakonda KC; Seely KA; Bratton SM; Brents LK; Moran CL; Endres GW; James LP; Hollenberg PF; Prather PL; Radominska-Pandya A; Moran JH
    Drug Metab Dispos; 2012 Nov; 40(11):2174-84. PubMed ID: 22904561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue.
    Sobolevsky T; Prasolov I; Rodchenkov G
    Drug Test Anal; 2015 Feb; 7(2):131-42. PubMed ID: 25428705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes.
    Kong TY; Kim JH; Choi WG; Lee JY; Kim HS; Kim JY; In MK; Lee HS
    Anal Bioanal Chem; 2017 Feb; 409(6):1667-1680. PubMed ID: 27924364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDP-glucuronosyltransferases.
    Illingworth NA; Boddy AV; Daly AK; Veal GJ
    Br J Pharmacol; 2011 Feb; 162(4):989-99. PubMed ID: 21054342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
    Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
    Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s.
    Kim JH; Kim HS; Kong TY; Lee JY; Kim JY; In MK; Lee HS
    J Pharm Biomed Anal; 2016 Feb; 119():50-8. PubMed ID: 26641707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Kinetic Characterization of Axitinib Metabolism.
    Zientek MA; Goosen TC; Tseng E; Lin J; Bauman JN; Walker GS; Kang P; Jiang Y; Freiwald S; Neul D; Smith BJ
    Drug Metab Dispos; 2016 Jan; 44(1):102-14. PubMed ID: 26512042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22).
    Jones S; Yarbrough AL; Shoeib A; Bush JM; Fantegrossi WE; Prather PL; Radominska-Pandya A; Fujiwara R
    Xenobiotica; 2019 Dec; 49(12):1388-1395. PubMed ID: 30739533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 530348 (Vorapaxar), a potent oral thrombin protease-activated receptor 1 antagonist.
    Ghosal A; Lu X; Penner N; Gao L; Ramanathan R; Chowdhury SK; Kishnani NS; Alton KB
    Drug Metab Dispos; 2011 Jan; 39(1):30-8. PubMed ID: 20926621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel substrates for human cytochrome P450 2J2.
    Lee CA; Neul D; Clouser-Roche A; Dalvie D; Wester MR; Jiang Y; Jones JP; Freiwald S; Zientek M; Totah RA
    Drug Metab Dispos; 2010 Feb; 38(2):347-56. PubMed ID: 19923256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
    Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
    Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine.
    Topletz AR; Dennison JB; Barbuch RJ; Hadden CE; Hall SD; Renbarger JL
    Drug Metab Dispos; 2013 Sep; 41(9):1651-61. PubMed ID: 23780963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation of the antiretroviral drug etravirine: metabolite identification, reaction phenotyping, and characterization of autoinduction of cytochrome P450-dependent metabolism.
    Yanakakis LJ; Bumpus NN
    Drug Metab Dispos; 2012 Apr; 40(4):803-14. PubMed ID: 22269145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11.
    Nielsen LM; Holm NB; Olsen L; Linnet K
    Drug Test Anal; 2016 Aug; 8(8):792-800. PubMed ID: 26360322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of human cytochrome P450 enzymes involved in the hepatic and intestinal biotransformation of 20(S)-protopanaxadiol.
    Chiu NT; Tomlinson Guns ES; Adomat H; Jia W; Deb S
    Biopharm Drug Dispos; 2014 Mar; 35(2):104-18. PubMed ID: 24151189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of dolasetron. Comparison with other indole-containing 5-HT3 antagonists.
    Sanwald P; David M; Dow J
    Drug Metab Dispos; 1996 May; 24(5):602-9. PubMed ID: 8723743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.